Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Goddeeris MM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vishy CE; Division of Nephrology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, and Kidney Research Institute, University of Washington, Seattle, WA 98109, USA., Thomas C; Division of Nephrology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, and Kidney Research Institute, University of Washington, Seattle, WA 98109, USA., Vincent T; Division of Nephrology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, and Kidney Research Institute, University of Washington, Seattle, WA 98109, USA., Crawford DK; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451, USA., Goddeeris MM; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451, USA., Freedman BS; Division of Nephrology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, and Kidney Research Institute, University of Washington, Seattle, WA 98109, USA; Plurexa, 1209 6th Ave. N., Seattle, WA 98109, USA. Electronic address: benof@uw.edu.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2024 Apr 04; Vol. 31 (4), pp. 537-553.e5.
Autor:
Crawford DK; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451 USA., Mullenders J; Hubrecht Organoid Technology, Yalelaan 62, 3584 CM Utrecht, the Netherlands., Pott J; Hubrecht Organoid Technology, Yalelaan 62, 3584 CM Utrecht, the Netherlands., Boj SF; Hubrecht Organoid Technology, Yalelaan 62, 3584 CM Utrecht, the Netherlands., Landskroner-Eiger S; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451 USA., Goddeeris MM; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA 02451 USA. Electronic address: matthew.goddeeris@eloxxpharma.com.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2021 May; Vol. 20 (3), pp. 436-442. Date of Electronic Publication: 2021 Feb 05.
Autor:
Crawford DK; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA, 02451, USA., Vanlandingham P; EyeCRO, 5301 North Beverly Drive, Oklahoma City, OK, 73105, USA., Schneider S; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA, 02451, USA., Goddeeris MM; Eloxx Pharmaceuticals, Inc., 950 Winter Street, Waltham, MA, 02451, USA. Electronic address: matthew.goddeeris@eloxxpharma.com.
Publikováno v:
Experimental eye research [Exp Eye Res] 2020 Dec; Vol. 201, pp. 108274. Date of Electronic Publication: 2020 Oct 02.
Autor:
Crawford DK; Eloxx Pharmaceuticals, Inc., Waltham, Massachusetts., Alroy I; Eloxx Pharmaceuticals, Inc., Waltham, Massachusetts., Sharpe N; Eloxx Pharmaceuticals, Inc., Waltham, Massachusetts., Goddeeris MM; Eloxx Pharmaceuticals, Inc., Waltham, Massachusetts matthew.goddeeris@eloxxpharma.com., Williams G; Eloxx Pharmaceuticals, Inc., Waltham, Massachusetts.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Aug; Vol. 374 (2), pp. 264-272. Date of Electronic Publication: 2020 May 06.
Autor:
Lagu B, Kluge AF, Tozzo E, Fredenburg R, Bell EL, Goddeeris MM, Dwyer P, Basinski A, Senaiar RS, Jaleel M, Tiwari NK, Panigrahi SK, Krishnamurthy NR, Takahashi T, Patane MA
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2019 Apr 24; Vol. 10 (6), pp. 1013. Date of Electronic Publication: 2019 Apr 24 (Print Publication: 2019).
Autor:
Lagu B; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Kluge AF; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Tozzo E; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Fredenburg R; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Bell EL; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Goddeeris MM; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Dwyer P; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Basinski A; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States., Senaiar RS; Aurigene Discovery Technologies, Ltd., Bengaluru and Hyderabad, India., Jaleel M; Aurigene Discovery Technologies, Ltd., Bengaluru and Hyderabad, India., Tiwari NK; Aurigene Discovery Technologies, Ltd., Bengaluru and Hyderabad, India., Panigrahi SK; Aurigene Discovery Technologies, Ltd., Bengaluru and Hyderabad, India., Krishnamurthy NR; Aurigene Discovery Technologies, Ltd., Bengaluru and Hyderabad, India., Takahashi T; Astellas Pharma., Tsukuba, Japan., Patane MA; Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma.), 1030 Massachusetts Avenue, Cambridge, Massachusetts 02138, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Jul 31; Vol. 9 (9), pp. 935-940. Date of Electronic Publication: 2018 Jul 31 (Print Publication: 2018).
Autor:
Lagu B; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States. Electronic address: blagu@mitobridge.com., Kluge AF; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States., Goddeeris MM; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States., Tozzo E; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States., Fredenburg RA; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States., Chellur S; Aurigene Discovery Technologies, Ltd., Bengaluru, Karnataka, India., Senaiar RS; Aurigene Discovery Technologies, Ltd., Bengaluru, Karnataka, India., Jaleel M; Aurigene Discovery Technologies, Ltd., Bengaluru, Karnataka, India., Babu DRK; Aurigene Discovery Technologies, Ltd., Bengaluru, Karnataka, India., Tiwari NK; Aurigene Discovery Technologies, Ltd., Bengaluru, Karnataka, India., Takahashi T; Astellas Pharma, Tsukuba, Japan., Patane MA; Mitobridge, Inc., 1030 Massachusetts Ave., Cambridge, MA 02138, United States.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Feb 01; Vol. 28 (3), pp. 533-536. Date of Electronic Publication: 2017 Nov 04.
Autor:
Goddeeris MM; 1] Howard Hughes Medical Institute, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242, USA [2] Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242, USA., Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP
Publikováno v:
Nature [Nature] 2013 Nov 07; Vol. 503 (7474), pp. 136-40. Date of Electronic Publication: 2013 Oct 16.